The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

(2017) Ingrid Pabinger et al.   THROMBOSIS AND HAEMOSTASIS

Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation

(2016) José Alexandre Ferreira et al.   DRUG RESISTANCE UPDATES

Heparanase: From basic research to therapeutic applications in cancer and inflammation

(2016) Israel Vlodavsky et al.   DRUG RESISTANCE UPDATES

Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol

(2016) Holger J Schünemann et al.   BMJ Open

Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells

(2015) Daniel Bastian Pfankuchen et al.   BIOCHEMICAL PHARMACOLOGY

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

(2015) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism

(2015) Guo-xing Zhong et al.   TUMOR BIOLOGY

The effect of small-molecular-weight heparin added to chemotherapy on survival in small-cell lung cancer - A retrospective analysis

(2014) M Altinbas et al.   INDIAN JOURNAL OF CANCER

Tackling the cancer stem cells — what challenges do they pose?

(2014) Diwakar R. Pattabiraman et al.   NATURE REVIEWS DRUG DISCOVERY

Heparan sulfate signaling in cancer

(2014) Erik H. Knelson et al.   TRENDS IN BIOCHEMICAL SCIENCES

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

(2012) Ahmed Y. Ali et al.   Annals of the New York Academy of Sciences

Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance by Inducing Proteasome-Mediated ABCG2 Protein Degradation

(2012) Qi Niu et al.   PLoS One

Optimization of Small-Cell Lung Cancer Chemotherapy with Heparin: A Comprehensive Retrospective Study of 239 Patients Treated in a Single Specialized Center

(2011) Bernard Lebeau et al.   CHEMOTHERAPY

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management

(2010) M. Mandala et al.   ANNALS OF ONCOLOGY